Compared with low-XBP1 group, BC patients in the high-XBP1 group had lower levels of immune-related gene sets (Figure 7A), lower tumour purity (Figure 7B) and higher immune scores and higher stromal scores (Figure 7C). This evidence concerns the gene XBP1 and neoplasm.